These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36820554)

  • 1. Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma.
    Huang Q; Yan J; Jiang Q; Guo F; Mo L; Deng T
    Medicine (Baltimore); 2023 Feb; 102(6):e32793. PubMed ID: 36820554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma.
    Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z
    Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.
    Zhou W; Zhang W
    BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
    Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
    Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
    Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
    Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.
    Qu G; Wang D; Xu W; Guo W
    Front Genet; 2022; 13():867627. PubMed ID: 35559014
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
    He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
    Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer.
    Xue S; Shen K; Wang K; Ge W; Mao T; Li S; Zhang X; Xu H; Wang Y; Yao J; Yue M; Ma J; Wang Y; Shentu D; Cui J; Wang L
    Dis Markers; 2022; 2022():5634887. PubMed ID: 36618967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy.
    Zhou X; Yao L; Zhou X; Cong R; Luan J; Wei X; Zhang X; Song N
    Front Oncol; 2022; 12():837155. PubMed ID: 35860590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
    Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
    Front Immunol; 2022; 13():961933. PubMed ID: 35990696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma.
    Xing Z; Liu Z; Fu X; Zhou S; Liu L; Dang Q; Guo C; Ge X; Lu T; Zheng Y; Dai L; Han X; Wang X
    Front Cell Dev Biol; 2022; 10():805291. PubMed ID: 35223836
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of prognostic markers for gastric cancer and comprehensive analysis of pyroptosis-related long non-coding RNAs.
    Wang Y; Li D; Xun J; Wu Y; Wang HL
    World J Gastrointest Surg; 2024 Jul; 16(7):2281-2295. PubMed ID: 39087128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic characterization of the pyroptosis-related subtypes and tumor microenvironment infiltration in glioma.
    He J; Zhou W; Zhang M
    Cancer Biomark; 2023; 37(3):161-177. PubMed ID: 37248887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue.
    Ma S; Zhao H; Wang F; Peng L; Zhang H; Wang Z; Jiang F; Zhang D; Yin M; Li S; Huang J; Liu Z; Tao S
    Aging (Albany NY); 2023 Mar; 15(5):1628-1651. PubMed ID: 36917093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic signature of pyroptosis-related lncRNAs verified in gastric cancer samples to predict the immunotherapy and chemotherapy drug sensitivity.
    Wang Y; Chen X; Jiang F; Shen Y; Fang F; Li Q; Yang C; Dong Y; Shen X
    Front Genet; 2022; 13():939439. PubMed ID: 36147488
    [No Abstract]   [Full Text] [Related]  

  • 20. Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer.
    Li R; Zhao M; Sun M; Miao C; Lu J
    PeerJ; 2023; 11():e15884. PubMed ID: 37671354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.